His most important project, however, is the one he’s currently leading as the national government advisor for mRNA cancer vaccines. This new type of vaccine, which is based on the same ...

The Novavax's COVID vaccine was approved by the US Food and Drug Administration for people age 12 and older in August 2024. This places it alongside Moderna's and Pfizer-BioNTech's refreshed formulas.